Do analysts rate GRML or ALDX?

Aldeyra Therapeutics has a consensus price target of $5.50, suggesting a potential upside of 142.29%. Given Aldeyra Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aldeyra Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Aldeyra Therapeutics 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, GRML or ALDX?

Aldeyra Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A Aldeyra Therapeutics N/A N/A -$33.85M -$0.46 N/A

Is GRML or ALDX more profitable?

Aldeyra Therapeutics' return on equity of -57.34% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Aldeyra Therapeutics N/A -57.34% -36.33%

Do analysts recommend GRML or PLYX?

Polaryx Therapeutics has a consensus price target of $10.00, suggesting a potential upside of 255.87%. Given Polaryx Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Polaryx Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Polaryx Therapeutics 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has stronger earnings & valuation, GRML or PLYX?

Polaryx Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A Polaryx Therapeutics N/A N/A N/A -$0.05 N/A

Is GRML or PLYX more profitable?

Polaryx Therapeutics' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Polaryx Therapeutics N/A N/A N/A

Do analysts prefer CUE or GRML?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cue Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend GRML or FTLF?

FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 86.96%. Given FitLife Brands' stronger consensus rating and higher possible upside, analysts plainly believe FitLife Brands is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 FitLife Brands 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts prefer GRML or ONCY?

Oncolytics Biotech has a consensus target price of $8.50, suggesting a potential upside of 845.39%. Given Oncolytics Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Oncolytics Biotech is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Oncolytics Biotech 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.75

Which has preferable valuation & earnings, GRML or ONCY?

Oncolytics Biotech is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A Oncolytics Biotech N/A N/A -$28.76M -$0.31 N/A

Is GRML or ONCY more profitable?

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Oncolytics Biotech's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Oncolytics Biotech N/A -2,185.97% -321.54%

Greenland Mines Ltd. Common Stock (GRML) Competitors

$0.23 0.00 (0.00%)

As of 07/2/2026 04:00 PM Eastern

Compare

GRML vs. ALDX, PLYX, CUE, FTLF, and ONCY

Should you buy Greenland Mines Ltd. Common Stock stock or one of its competitors? MarketBeat compares Greenland Mines Ltd. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Greenland Mines Ltd. Common Stock include Aldeyra Therapeutics (ALDX), Polaryx Therapeutics (PLYX), Cue Biopharma (CUE), FitLife Brands (FTLF), and Oncolytics Biotech (ONCY). These companies are all part of the "pharmaceutical products" industry.

How does Greenland Mines Ltd. Common Stock compare to Aldeyra Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Aldeyra Therapeutics (NASDAQ:ALDX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, media sentiment, risk, valuation, institutional ownership, profitability, dividends and analyst recommendations.

Greenland Mines Ltd. Common Stock has a beta of 7.05, indicating that its share price is 605% more volatile than the broader market. Comparatively, Aldeyra Therapeutics has a beta of 1.16, indicating that its share price is 16% more volatile than the broader market.

Aldeyra Therapeutics has a consensus price target of $5.50, suggesting a potential upside of 142.29%. Given Aldeyra Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Aldeyra Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Aldeyra Therapeutics	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aldeyra Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Aldeyra Therapeutics	N/A	N/A	-$33.85M	-$0.46	N/A

Aldeyra Therapeutics' return on equity of -57.34% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Aldeyra Therapeutics	N/A	-57.34%	-36.33%

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 59.7% of Aldeyra Therapeutics shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Comparatively, 11.8% of Aldeyra Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than Aldeyra Therapeutics. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for Aldeyra Therapeutics. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.30 beat Aldeyra Therapeutics' score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Neutral
Aldeyra Therapeutics	Neutral

Summary

Aldeyra Therapeutics beats Greenland Mines Ltd. Common Stock on 7 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Polaryx Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Polaryx Therapeutics (NASDAQ:PLYX) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Polaryx Therapeutics has a consensus price target of $10.00, suggesting a potential upside of 255.87%. Given Polaryx Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Polaryx Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Polaryx Therapeutics	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Polaryx Therapeutics' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Polaryx Therapeutics	N/A	N/A	N/A

In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than Polaryx Therapeutics. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for Polaryx Therapeutics. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.30 beat Polaryx Therapeutics' score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Neutral
Polaryx Therapeutics	Neutral

20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Polaryx Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Polaryx Therapeutics	N/A	N/A	N/A	-$0.05	N/A

Summary

Polaryx Therapeutics beats Greenland Mines Ltd. Common Stock on 6 of the 11 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Cue Biopharma?

Cue Biopharma (NASDAQ:CUE) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cue Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to Cue Biopharma's net margin of -59.65%. Cue Biopharma's return on equity of -98.30% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cue Biopharma	-59.65%	-98.30%	-53.69%
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%

In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than Cue Biopharma. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for Cue Biopharma. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.30 beat Cue Biopharma's score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the news media.

Company	Overall Sentiment
Cue Biopharma	Neutral
Greenland Mines Ltd. Common Stock	Neutral

35.0% of Cue Biopharma shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 14.6% of Cue Biopharma shares are held by company insiders. Comparatively, 11.3% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Greenland Mines Ltd. Common Stock has lower revenue, but higher earnings than Cue Biopharma. Cue Biopharma is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cue Biopharma	$32.73M	3.63	-$26.60M	-$5.58	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Cue Biopharma has a beta of 2.45, indicating that its stock price is 145% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 7.05, indicating that its stock price is 605% more volatile than the broader market.

Summary

Greenland Mines Ltd. Common Stock beats Cue Biopharma on 7 of the 12 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to FitLife Brands?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, media sentiment, institutional ownership, risk, earnings and dividends.

FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 86.96%. Given FitLife Brands' stronger consensus rating and higher possible upside, analysts plainly believe FitLife Brands is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
FitLife Brands	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

FitLife Brands has higher revenue and earnings than Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
FitLife Brands	$81.46M	1.33	$6.33M	$0.60	19.17

Greenland Mines Ltd. Common Stock has a beta of 7.05, suggesting that its stock price is 605% more volatile than the broader market. Comparatively, FitLife Brands has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 2.3% of FitLife Brands shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 61.7% of FitLife Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than FitLife Brands. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for FitLife Brands. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.30 beat FitLife Brands' score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Neutral
FitLife Brands	Neutral

FitLife Brands has a net margin of 6.64% compared to Greenland Mines Ltd. Common Stock's net margin of 0.00%. FitLife Brands' return on equity of 18.31% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
FitLife Brands	6.64%	18.31%	8.21%

Summary

FitLife Brands beats Greenland Mines Ltd. Common Stock on 11 of the 15 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Oncolytics Biotech?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Oncolytics Biotech (NASDAQ:ONCY) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Oncolytics Biotech is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Oncolytics Biotech	N/A	N/A	-$28.76M	-$0.31	N/A

In the previous week, Greenland Mines Ltd. Common Stock had 2 more articles in the media than Oncolytics Biotech. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 0 mentions for Oncolytics Biotech. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.30 beat Oncolytics Biotech's score of 0.00 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Neutral
Oncolytics Biotech	Neutral

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Oncolytics Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Oncolytics Biotech	N/A	-2,185.97%	-321.54%

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 6.8% of Oncolytics Biotech shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 0.1% of Oncolytics Biotech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Oncolytics Biotech has a consensus target price of $8.50, suggesting a potential upside of 845.39%. Given Oncolytics Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Oncolytics Biotech is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Oncolytics Biotech	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.75

Greenland Mines Ltd. Common Stock has a beta of 7.05, suggesting that its stock price is 605% more volatile than the broader market. Comparatively, Oncolytics Biotech has a beta of 1.09, suggesting that its stock price is 9% more volatile than the broader market.

Summary

Greenland Mines Ltd. Common Stock beats Oncolytics Biotech on 9 of the 14 factors compared between the two stocks.

Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRML vs. The Competition

Export

Metric	Greenland Mines Ltd. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$32.05M	$3.10B	$7.16B	$12.48B
Dividend Yield	N/A	2.05%	2.66%	6.52%
P/E Ratio	-0.73	20.06	28.02	24.70
Price / Sales	N/A	360.33	540.37	99.49
Price / Cash	N/A	57.49	49.26	57.09
Price / Book	1.78	4.32	10.96	6.46
Net Income	-$10.55M	$64.45M	$3.57B	$337.01M
7 Day Performance	-9.34%	2.97%	2.12%	1.69%
1 Month Performance	-24.43%	6.83%	5.25%	3.81%
1 Year Performance	-79.65%	29.07%	33.29%	23.90%

Greenland Mines Ltd. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRML Greenland Mines Ltd. Common Stock	0.6366 of 5 stars	$0.23 flat	N/A	-79.6%	$32.05M	N/A	N/A	5	Gap Up
ALDX Aldeyra Therapeutics	3.1749 of 5 stars	$1.90 -6.2%	$5.50 +190.2%	-47.3%	$114.31M	N/A	N/A	10
PLYX Polaryx Therapeutics	2.0015 of 5 stars	$2.39 -0.8%	$10.00 +318.4%	N/A	$112.40M	N/A	N/A	11	Analyst Upgrade
CUE Cue Biopharma	0.1738 of 5 stars	$26.40 -1.8%	N/A	-95.4%	$111.30M	$27.47M	N/A	60	Gap Up
FTLF FitLife Brands	4.5314 of 5 stars	$11.85 flat	$21.50 +81.4%	-18.4%	$111.27M	$81.46M	19.62	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GRML) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ALDX, PLYX, CUE, FTLF, and ONCY

How does Greenland Mines Ltd. Common Stock compare to Aldeyra Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Polaryx Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Cue Biopharma?

Summary

How does Greenland Mines Ltd. Common Stock compare to FitLife Brands?

Summary

How does Greenland Mines Ltd. Common Stock compare to Oncolytics Biotech?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ALDX, PLYX, CUE, FTLF, and ONCY

How does Greenland Mines Ltd. Common Stock compare to Aldeyra Therapeutics?

Which has more risk & volatility, GRML or ALDX?

Do analysts rate GRML or ALDX?

Which has higher valuation & earnings, GRML or ALDX?

Is GRML or ALDX more profitable?

Do institutionals and insiders hold more shares of GRML or ALDX?

Does the media prefer GRML or ALDX?

Summary

How does Greenland Mines Ltd. Common Stock compare to Polaryx Therapeutics?

Do analysts recommend GRML or PLYX?

Is GRML or PLYX more profitable?

Does the media favor GRML or PLYX?

Do institutionals & insiders hold more shares of GRML or PLYX?

Which has stronger earnings & valuation, GRML or PLYX?

Summary

How does Greenland Mines Ltd. Common Stock compare to Cue Biopharma?

Do analysts prefer CUE or GRML?

Is CUE or GRML more profitable?

Does the media favor CUE or GRML?

Do insiders and institutionals hold more shares of CUE or GRML?

Which has better valuation & earnings, CUE or GRML?

Which has more volatility and risk, CUE or GRML?

Summary

How does Greenland Mines Ltd. Common Stock compare to FitLife Brands?

Do analysts recommend GRML or FTLF?

Which has stronger earnings & valuation, GRML or FTLF?

Which has more volatility and risk, GRML or FTLF?

Do institutionals and insiders have more ownership in GRML or FTLF?

Does the media refer more to GRML or FTLF?

Is GRML or FTLF more profitable?

Summary

How does Greenland Mines Ltd. Common Stock compare to Oncolytics Biotech?

Which has preferable valuation & earnings, GRML or ONCY?

Does the media refer more to GRML or ONCY?

Is GRML or ONCY more profitable?

Do institutionals and insiders believe in GRML or ONCY?

Do analysts prefer GRML or ONCY?

Which has more volatility & risk, GRML or ONCY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools